CEO Salary & Executive Compensation
Regeneron REGN
CEO: Leonard Schleifer · Biotechnology · 14,000 employees
Leonard Schleifer, CEO of Regeneron (REGN), earned $12.0M in total compensation in 2025. Regeneron receives a Pay-for-Performance grade of A (83/100), with a CEO-to-worker pay ratio of 96:1 and a say-on-pay shareholder approval of 89.2%. The company's 3-year total shareholder return is +22.7%.
How Regeneron CEO Pay Compares
Leonard Schleifer's $12.0M total compensation is 0% below the Biotechnology industry median of $12.0M. The 96:1 CEO-to-worker pay ratio is 4% higher than the industry average of 92:1.
Total compensation for Leonard Schleifer at Regeneron (REGN) was $12.0M. Mid-cap public-company CEO packages tend to track this pattern — equity-heavy, multi-year vesting, performance-tied.
The CEO-to-median-worker pay ratio runs 96x. Lower ratios typically reflect companies with higher-paid workforces (financial services, technology, professional services) where the median worker pay denominator is itself substantial. Performance has been positive over the three-year window: TSR of 22.7% alongside 19.6% revenue growth. Compensation packages tied to relative TSR or absolute return benchmarks would have vested at or near target levels with this performance profile.
Say-on-pay support was strong at 89%. The Dodd-Frank-mandated advisory vote on executive compensation passes at most U.S. public companies with comfortable margins; meaningful dissent typically requires either pay-performance misalignment or specific governance concerns. Regeneron operates in Biotechnology with 14,000 employees and $13.1B in annual revenue, and currently carries a market capitalization of $100.0B. Pay comparisons across companies require controlling for these structural factors — a $20M package at a $10B-revenue tech company reads differently than the same package at a $1B-revenue industrial.
Source: SEC EDGAR — DEF 14A proxy statements for Regeneron (REGN).
Compensation Breakdown
Leonard Schleifer's $12.0M total compensation package for fiscal year 2025 includes $1.2M in base salary, $6.0M in stock awards, $1.4M in option awards, and $1.8M in bonus and non-equity incentives.
Compensation History
| Year | Salary | Bonus | Stock Awards | Options | Non-Equity | Other | Total |
|---|---|---|---|---|---|---|---|
| 2025 | $1.2M | - | $6.0M | $1.4M | $1.8M | $1.3M | $12.0M |
| 2024 | $1.2M | - | $6.0M | $1.4M | $1.8M | $1.3M | $12.0M |
| 2023 | $1.2M | - | $6.0M | $1.4M | $1.8M | $1.3M | $12.0M |
| 2022 | $1.2M | - | $6.0M | $1.4M | $1.8M | $1.3M | $12.0M |
All compensation data is sourced from SEC DEF 14A proxy filings submitted to EDGAR. The Economic Policy Institute's CEO pay analysis provides additional context on executive compensation trends across industries.
Named Executive Officers
Peer CEO Compensation
Leonard Schleifer, CEO of Regeneron (REGN), earns $12.0M in total compensation. This includes base salary, stock awards, option awards, and other incentives as reported in the company's most recent DEF 14A proxy statement.
Frequently Asked Questions
Leonard Schleifer, CEO of Regeneron (REGN), earns $12.0M in total compensation. This includes base salary, stock awards, option awards, and other incentives as reported in the company's most recent DEF 14A proxy statement.
Regeneron has a Pay-for-Performance Score of A (83/100). The company's 3-year total shareholder return is +22.7%, and the say-on-pay shareholder vote passed with 89.2% approval.
The CEO-to-median-worker pay ratio at Regeneron is 96:1. The median worker at Regeneron earns $125K per year, while CEO Leonard Schleifer earns $12.0M in total compensation.
Regeneron employs approximately 14,000 people. The company operates in the Biotechnology industry within the Healthcare sector, generating $13.1B in annual revenue.